Our Team
Innovac Therapeutics is a biotechnology company dedicated to developing innovative vaccines for patients with unmet medical needs, using our proprietary RNA technology platforms and manufacturing capabilities.
Founders
Michael (Chi) Zhang, MD
Co-Founder, Chief Executive Officer
Nicholas Valiante, PhD
Co-Founder, Chief Scientific Officer, President
Hang Yuan, PhD
Co-Founder, Chief Technical Officer
Leadership Team
John R. Haserick, PhD
VP, Platform Development
Shiteshu Shrimal, PhD
VP, Biology
Monia Draghi, PhD
VP, Immunology
Missy Fulton
Head of People Strategy
Sheri Barrack, PhD
Head of Regulatory & Quality
